https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/researchers-identify-molecular-drivers-most-common-type-childhood-brain-tumour/
Researchers identify molecular drivers of most common type of childhood brain tumour
22 Mar 2016, 6:32 p.m.

A team of researchers has identified the molecular drivers behind the most common type of paediatric brain tumour.The research, from teams working at Great Ormond Street Hospital, the UCL Institute of Child Health and four other research institutions could improve the treatment of children with a type of brain tumour known as pilocytic astrocytoma.
The researchers carried out tests on brain tumour samples taken from 57 children, detailing microRNA (mRNA) and gene expression profiles alongside a pathway analysis. The findings suggested that there is a distinctive mRNA and gene expression profile in pilocytic astrocytoma when compared to other paediatric brain tumours.
Researchers found mRNA to be up-regulated and it is suggested that the resulting effect on the ERK/MAPK pathway contributes to the unique phenotype of pilocytic astrocytoma.
Pilocytic astrocytomas are the most common type of central nervous tumours in children. They are often slow growing, cystic well-circumscribed tumours that are most commonly situated within the cerebellum, making the removal of the tumour possible. However, many children are left with significant chronic disabilities following treatment.
The Great Ormond Street BRC supported the study, which is published in Acta Neuropathologica Communications.

GOSH contributes to landmark UAE-UK paper on AI in healthcare
We're proud to have contributed to a new paper published by the UAE-UK Business Council, exploring future opportunities for collaboration in artificial intelligence (AI) in healthcare between the United Kingdom and the United Arab Emirates.

Landmark gene therapy study shows safety for children
Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment.

New study pinpoints why some transplanted kidneys are rejected
Researchers at University College London (UCL), the Wellcome Sanger Institute and the University of Cambridge combined technology that determines the genetic or RNA sequence of individual cells with powerful 3D imaging to look at lymphatic vessels

Scientists discover clues to help children with rare muscle disease
New ground-breaking research by experts at Great Ormond Street Hospital (GOSH) and University College London (UCL) has led to an exciting discovery that could help children with the rare muscle disease, juvenile dermatomyositis (JDM).